We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

PREDATOR: Neoadjuvant Gene Prediction for Breast Cancer

This study has been terminated.
(Funding agent withdrew funding)
Sponsor:
ClinicalTrials.gov Identifier:
NCT02067416
First Posted: February 20, 2014
Last Update Posted: September 14, 2016
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborators:
GE Healthcare
The Methodist Hospital System
Information provided by (Responsible Party):
Angel Augusto Rodriguez, MD, The Methodist Hospital System
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: June 2014
  Primary Completion Date: June 2014 (Final data collection date for primary outcome measure)